FDA Drug Application (204326) for ADZENYS XR-ODT by NEOS THERAPS

Back to FDA Applications sponsored by NEOS THERAPS

Application Number204326
Product Number001
FormTABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
DosageEQ 3.1MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameADZENYS XR-ODT
Active IngredientAMPHETAMINE

Active IngredientCount
List of drugs with Active Ingredient AMPHETAMINE2


Back to FDA Applications sponsored by NEOS THERAPS